Psychotic Disorders - Saudi Arabia

Revenue in the Psychotic Disorders market is projected to reach US$47.38m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.10%, resulting in a market volume of US$47.62m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$118.20 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Saudi Arabia has been experiencing significant growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Psychotic Disorders market in Saudi Arabia have been shifting towards a greater emphasis on mental health and well-being. With increasing awareness and understanding of mental health issues, there is a growing demand for effective treatments for psychotic disorders. Customers are seeking innovative and personalized solutions that can provide relief from symptoms and improve their overall quality of life. This has led to a rise in the demand for medications, therapy sessions, and other forms of treatment for psychotic disorders.Trends in the market indicate a growing focus on holistic approaches to treating psychotic disorders in Saudi Arabia. Healthcare providers are adopting a multidimensional approach that includes medication management, therapy, and lifestyle changes. This trend is driven by the recognition that treating psychotic disorders requires addressing not only the symptoms but also the underlying causes and contributing factors. As a result, there is a growing demand for integrated treatment programs that combine medication, therapy, and lifestyle interventions.Local special circumstances in Saudi Arabia, such as cultural beliefs and social stigmas surrounding mental health, have also influenced the development of the Psychotic Disorders market. In the past, mental health issues were often stigmatized and not openly discussed. However, there has been a gradual shift in societal attitudes, with a greater recognition of the importance of mental health and the need for appropriate treatment. This change in perception has created a more conducive environment for the growth of the Psychotic Disorders market in Saudi Arabia.Underlying macroeconomic factors, such as a growing population, increasing healthcare expenditure, and government initiatives to improve mental healthcare services, have also contributed to the development of the Psychotic Disorders market in Saudi Arabia. The country's population is expanding, leading to a larger pool of potential customers for mental healthcare services. Additionally, the government has been investing in the healthcare sector, including mental health services, to improve access and quality of care. These factors have created a favorable market environment for the growth of the Psychotic Disorders market in Saudi Arabia.In conclusion, the Psychotic Disorders market in Saudi Arabia is developing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. With a greater focus on mental health and well-being, a shift towards holistic treatment approaches, changing societal attitudes, and favorable macroeconomic conditions, the market is expected to continue its growth trajectory in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.